The UK's health secretary, Andrew Lansley, is accepting proposals for a new regulatory body that would speed up applications by scientists carrying out health research, and open up the UK — to a greater degree — to drug companies wanting to carry out clinical trials, reports The Guardian's Sarah Boseley.